openPR Logo
Press release

Investors who lost money with shares of Alarum Technologies Ltd. (NASDAQ: ALAR) should contact the Shareholders Foundation with the pending lawsuit

A lawsuit was filed on behalf of investors in Alarum Technologies Ltd. (NASDAQ: ALAR) shares.

A lawsuit was filed on behalf of investors in Alarum Technologies Ltd. (NASDAQ: ALAR) shares.

An investor, who purchased shares of Alarum Technologies Ltd. (NASDAQ: ALAR), filed a lawsuit over alleged violations of Federal Securities Laws by Alarum Technologies Ltd. in connection with certain allegedly false and misleading statements.

Investors who purchased shares of Alarum Technologies Ltd. (NASDAQ: ALAR), have certain options and for certain investors are short and strict deadlines running. Deadline: April 15, 2025. NASDAQ: ALAR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Tel Aviv, Israel based Alarum Technologies Ltd. provides internet access and web data collection solutions in North, South, and Central America, Europe, Southeast Asia, the Middle East, and Africa. The company operates through two segments, Enterprise Internet Access Solutions and Consumer Internet Access Solutions. Specifically, the Company generates SaaS revenues "when customers subscrib[e] to [its] enterprise and consumer access platforms and [pay] for the packages they choose." Given Alarum's concentrated customer base, the spending patterns of even a small number of customers can have a substantial impact on the Company's growth.
Alarum Technologies Ltd. has described itself as a "market leader" that has demonstrated "success in not only retaining, but also significantly expanding [its] engagements with existing customers." Alarum Technologies Ltd. (NASDAQ: ALAR) reported that ist annual Total Revenue rose from $18.55 million in 2022 to $26.52 million in 2023, and that its Net Loss declined from $13.15 million in 2022 to $5.52 million in 2023.

By June 2024 Alarum Technologies Ltd. began seeing reduced customer spending that ultimately resulted in a 20% revenue decrease from the prior month. Notwithstanding the foregoing, the Company consistently maintained at all relevant times that it "deliver[s] strong performance and value to [its] shareholders" and touted that its "revenues and operating cashflow reflect the dedication of [Alarum's] team and the robustness of [its] business model."
On August 26, 2024, Alarum Technologies Ltd. announced its results for the second quarter of 2024 and issued Q3 2024 guidance. Specifically, Alarum Technologies Ltd. revealed that it was expecting Q3 2024 revenue of $7 million, far short of the $9.2 million revenue figure projected by analysts.
That same day, Alarum Technologies Ltd. hosted an earnings call with investors and analysts to discuss the Company's Q2 2024 results, during which Alarum's Chief Executive Officer Shachar Daniel attributed the disappointing Q3 2024 revenue guidance to the reduced customer spending Alarum began experiencing in June 2024.
Market analysts were quick to comment on the Company's revelation. For example, on August 27, 2024, Seeking Alpha noted that Alarum's projected Q3 2024 revenue figure "represent[ed] over a 20% decline sequentially and only 3% growth [year-over-year]," and raised several issues with Alarum's disclosure including, among other things, the lack of clarity in the Company's explanation for the drop in customer demand.

Shares of Alarum Technologies Ltd. (NASDAQ: ALAR) declined from $46.69 per share on July 03, 2024, to as low as $5.86 per share on March 04, 2025.

The plaintiff claims that between March 14, 2024 and August 26, 2024, the Defendants made false and/or misleading statements and/or failed to disclose that the Company was less effective in retaining and/or expanding customer engagements than it had represented to investors, that the foregoing would impair Alarum's ability to generate consistent revenue growth, that accordingly, Alarum's business and/or financial prospects were overstated; and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Alarum Technologies Ltd. (NASDAQ: ALAR) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investors who lost money with shares of Alarum Technologies Ltd. (NASDAQ: ALAR) should contact the Shareholders Foundation with the pending lawsuit here

News-ID: 3903418 • Views:

More Releases from Shareholders Foundation, Inc.

Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potential Wrongdoing
Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potentia …
An investigation on behalf of current long-term investors in shares of Novo Nordisk A/S (NYSE: NVO) concerning potential breaches of fiduciary duties by certain directors and officers was announced. Investors who are current long term investors in Novo Nordisk A/S (NYSE: NVO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for long term investors in
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ: FTNT)
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ …
An investor, who purchased shares of Fortinet, Inc. (NASDAQ: FTNT), filed a lawsuit over alleged violations of Federal Securities Laws by Fortinet, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fortinet, Inc. (NASDAQ: FTNT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 21, 2025. NASDAQ: FTNT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on October 07, 2025
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on Octob …
A deadline is coming up on October 07, 2025in the lawsuit filed for certain investors of CTO Realty Growth, Inc. (NYSE: CTO) over alleged securities laws violations by CTO Realty Growth, Inc. Investors who purchased shares of CTO Realty Growth, Inc. (NYSE: CTO) have certain options and there are strict and short deadlines running. Deadline: October 07, 2025. CTO Realty Growth, Inc. (NYSE: CTO) stockholders should contact the Shareholders Foundation at
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR)
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeu …
An investor, who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR), filed a lawsuit over alleged violations of Federal Securities Laws by Jasper Therapeutics, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 18, 2025. NASDAQ: JSPR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Alarum

Alarum Technologies Ltd. (NASDAQ: ALAR) Investor Alert: Deadline in Lawsuit on A …
A deadline is coming up on April 15, 2025 in the lawsuit filed for certain investors of Alarum Technologies Ltd. (NASDAQ: ALAR) over alleged securities laws violations by Alarum Technologies Ltd. Investors who purchased shares of Alarum Technologies Ltd. (NASDAQ: ALAR) have certain options and there are strict and short deadlines running. Deadline: April 15, 2025. Alarum Technologies Ltd. (NASDAQ: ALAR) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or